Patrick S. Kamath

Active 1987–2026

Also published as
Patrick S Kamath
252
Papers
54,151
Citations
108
h-index
238
i10-index

Citations

Citations per year for Patrick S. Kamath1984: 1 citations1985: 1 citations1986: 1 citations1988: 4 citations1989: 6 citations1990: 3 citations1991: 1 citations1992: 7 citations1993: 4 citations1994: 6 citations1996: 3 citations1997: 7 citations1998: 7 citations1999: 4 citations2000: 21 citations2001: 23 citations2002: 54 citations2003: 100 citations2004: 188 citations2005: 143 citations2006: 161 citations2007: 189 citations2008: 187 citations2009: 208 citations2010: 275 citations2011: 216 citations2012: 221 citations2013: 244 citations2014: 320 citations2015: 301 citations2016: 299 citations2017: 280 citations2018: 322 citations2019: 1,381 citations2020: 1,556 citations2021: 1,595 citations2022: 1,408 citations2023: 1,253 citations2024: 2,466 citations2025: 1,358 citations2026: 57 citations1987: no citations, so this year is not shown1995: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,909 citing papers, 23.6% of this breakdownChina: 2,240 citing papers, 13.5% of this breakdownUnited Kingdom: 1,012 citing papers, 6.1% of this breakdownSpain: 824 citing papers, 5% of this breakdownItaly: 810 citing papers, 4.9% of this breakdownGermany: 775 citing papers, 4.7% of this breakdownFrance: 627 citing papers, 3.8% of this breakdownCanada: 596 citing papers, 3.6% of this breakdownIndia: 468 citing papers, 2.8% of this breakdownJapan: 392 citing papers, 2.3% of this breakdownSouth Korea: 315 citing papers, 1.9% of this breakdownNetherlands: 301 citing papers, 1.8% of this breakdown
0%23.6%Other 26%

Fields

  • Medicine82%
  • Biochemistry, Genetics and Molecular Biology9.2%
  • Pharmacology, Toxicology and Pharmaceutics2.5%
  • Immunology and Microbiology1.5%
  • Engineering1%
  • Computer Science0.7%
  • Other3.1%

Topics

  • Liver Disease Diagnosis and Treatment14.9%
  • Liver Disease and Transplantation14.4%
  • Organ Transplantation Techniques and Outcomes5.7%
  • Alcohol Consumption and Health Effects3.4%
  • Hepatocellular Carcinoma Treatment and Prognosis3%
  • Liver physiology and pathology2.7%
  • Other55.9%

Coauthors

All papers

Open in search
  1. Global burden of liver disease: 2023 update

    Authors: , , , , , - Journal of Hepatology 2023 cited by 1,996

  2. Burden of liver diseases in the world

    Authors: , , , - Journal of Hepatology 2018 cited by 3,729

  3. Liver cirrhosis

    Authors: , , , , , - The Lancet 2021 cited by 1,501

  4. A Model to Predict Survival in Patients With End–Stage Liver Disease

    Authors: , , , , , , , , - Hepatology 2001 cited by 4,932

  5. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era

    Authors: , , , , , , , , - Gastroenterology 2021 cited by 589

  6. Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population

    Authors: , , , , , , , , - Hepatology Communications 2021 cited by 376

  7. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

    Authors: , , , , , - Hepatology 2000 cited by 2,899

  8. ACG Clinical Guideline: Alcoholic Liver Disease

    Authors: , , , , - The American Journal of Gastroenterology 2018 cited by 835

  9. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eva Bonfill, Marta Juan, Anna Sòria, Marta Carol, Jordi Gratacós‐Ginès, Rosa M. Morillas, Pere Torán‐Monserrat, J. M. Navarrete, Antoni Torrejón, Céline Fournier, Anne Llorca, Anita Arslanow, Harry J de Koning, Fernando Cucchietti, Michael P. Manns, Philip N. Newsome, Rubén Hernáez, Alina M. Allen, Paolo Angeli, Robert J. de Knegt, Tom H. Karlsen, Peter R. Galle, Vincent Wai‐Sun Wong, Núria Fabrellas, Laurent Castéra, Aleksander Krag, Frank Lammert, Patrick S Kamath, Pere Ginès, Marifé Alvarez, Peter Andersen, Paolo Angeli, Alba Ardèvol, Anita Arslanow, Luca Beggiato, Zahia Ben Abdesselam, Lucy Bennett, Bajiha Boutouria, Alessandra Brocca, M. Teresa Broquetas, M. Teresa Broquetas, Valeria Calvino, Judith Camacho, Aura Capdevila, Marta Carol, Laurent Castéra, Marta Cervera, Marta Cervera, Anna de Fuentes, Rob de Knegt, Rob de Knegt, Sönke Detlefsen, Alba Díaz, José Diéguez Bande, Vanessa Esnault, Núria Fabrellas, Josep Lluis Falcó, Rosa Fernández, Céline Fournier, Céline Fournier, Peter R. Galle, Edgar García, Montserrat Garcı́a-Retortillo, E.A González Garrido, Pere Ginès, Rosa Gordillo Medina, Jordi Gratacós‐Ginès, Isabel Graupera, Jordi Gratacós-Ginès, Indra Neil Guha and 78 more - The Lancet 2023 cited by 157

  10. Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2021 cited by 289

  11. Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List

    Authors: , , , , , , , - New England Journal of Medicine 2008 cited by 1,485

  12. The model for end-stage liver disease (MELD)

    Authors: , - Hepatology 2007 cited by 1,661

  13. Model for end-stage liver disease (MELD) and allocation of donor livers

    Authors: , , , , , , , , , , , - Gastroenterology 2003 cited by 2,524

  14. Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia

    Authors: , , , , , , , , , , , , , , - Gastroenterology 2016 cited by 535

  15. An Open‐Label, Dose‐Escalation Study to Assess the Safety and Efficacy of IL‐22 Agonist F‐652 in Patients With Alcohol‐associated Hepatitis

    Authors: , , , , , , , , , , , , , , , , , , , - Hepatology 2019 cited by 203

  16. Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2023 cited by 97

  17. Acute-on-Chronic Liver Failure Clinical Guidelines

    Authors: , , , , , , - The American Journal of Gastroenterology 2022 cited by 234

  18. Mechanical Stretch Increases Expression of CXCL1 in Liver Sinusoidal Endothelial Cells to Recruit Neutrophils, Generate Sinusoidal Microthombi, and Promote Portal Hypertension

    Authors: , , , , , , , , , , , , , , , , - Gastroenterology 2019 cited by 234

  19. Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year‐community study

    Authors: , , , , , - Hepatology 2017 cited by 378

  20. Acute-on-chronic liver failure in cirrhosis

    Authors: , , , , , , , , , - Nature Reviews Disease Primers 2016 cited by 431

  21. Clinical course of non-alcoholic fatty liver disease and the implications for clinical trial design

    Authors: , , , , , , , , - Journal of Hepatology 2022 cited by 120

  22. Evidence-Based Incorporation of Serum Sodium Concentration Into MELD

    Authors: , , , , , , , , , , , - Gastroenterology 2006 cited by 777

  23. The Evolving Challenge of Infections in Cirrhosis

    Authors: , , - New England Journal of Medicine 2021 cited by 205

  24. Survival in Infection-Related Acute-on-Chronic Liver Failure Is Defined by Extrahepatic Organ Failures

    Authors: , , , , , , , , , , , , - Hepatology 2014 cited by 573